CMS and FDA unveil a fast track for Medicare access to breakthrough devices

The Centers for Medicare & Medicaid Services (CMS) and the US Food and Drug Administration (FDA) have announced a new regulatory framework designed to accelerate Medicare coverage for certain FDA‑designated Class II and Class III breakthrough devices.

The goal of the new Regulatory Alignment for Predictable and Immediate Device